← 產業報告目錄
Physician Office Diagnostic Market Size, Share & Trends Analysis Report By Product Type (Point-of-Care Testing (POCT) Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, Urinalysis Systems), By End-User, By Application, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-28頁數 180報告編號 INSIGHTACE-8337ab6418
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Physician Office Diagnostic Market stood at USD 118.1 Bn in 2024, and is anticipated to reach USD 407.2 Bn by 2034, recording a CAGR of 13.3% from 2025 through 2034.
The Physician Office Diagnostic sector involves risingly being utilized by independent practises to effectively handle the expanding patient population afflicted with chronic medical ailments. This domain has witnessed meaningful transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is propelled by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Physician Office Diagnostic Market Snapshot
Chapter 4. Global Physician Office Diagnostic Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type, & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Product Type:
5.2.1. Point-of-Care Testing (POCT) Devices
5.2.2. Clinical Chemistry Analyzers
5.2.3. Immunoassay Systems
5.2.4. Molecular Diagnostics
5.2.5. Urinalysis Systems
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Application:
6.2.1. Infectious Diseases
6.2.2. Cardiovascular Disorders
6.2.3. Metabolic Disorders
6.2.4. Cancer Diagnosis
6.2.5. Pregnancy and Fertility Testing
Chapter 7. Market Segmentation 3: By End-User Estimates & Trend Analysis
7.1. By End-User & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By End-User:
7.2.1. Physician Offices and Clinics
7.2.2. Urgent Care Centers
7.2.3. Ambulatory Care Centers
Chapter 8. Physician Office Diagnostic Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Physician Office Diagnostic Market revenue (US$ Million) estimates and forecasts By Product Type, 2021-2034
8.1.2. North America Physician Office Diagnostic Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.1.3. North America Physician Office Diagnostic Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
8.1.4. North America Physician Office Diagnostic Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Physician Office Diagnostic Market revenue (US$ Million) By Product Type, 2021-2034
8.2.2. Europe Physician Office Diagnostic Market revenue (US$ Million) By Application, 2021-2034
8.2.3. Europe Physician Office Diagnostic Market revenue (US$ Million) By End-User, 2021-2034
8.2.4. Europe Physician Office Diagnostic Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Physician Office Diagnostic Market revenue (US$ Million) By Product Type, 2021-2034
8.3.2. Asia Pacific Physician Office Diagnostic Market revenue (US$ Million) By Application, 2021-2034
8.3.3. Asia Pacific Physician Office Diagnostic Market revenue (US$ Million) By End-User, 2021-2034
8.3.4. Asia Pacific Physician Office Diagnostic Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Physician Office Diagnostic Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
8.4.2. Latin America Physician Office Diagnostic Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.4.3. Latin America Physician Office Diagnostic Market revenue (US$ Million) By End-User, (US$ Million) 2021-2034
8.4.4. Latin America Physician Office Diagnostic Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Physician Office Diagnostic Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Physician Office Diagnostic Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Physician Office Diagnostic Market revenue (US$ Million) By End-User, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Physician Office Diagnostic Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Hoffmann-La Roche Ltd,
9.2.2. Siemens Healthineers AG,
9.2.3. Abbott Laboratories,
9.2.4. Thermo Fisher Scientific Inc.,
9.2.5. Danaher Corporation,
9.2.6. Sysmex Corporation,
9.2.7. Becton, Dickinson and Company,
9.2.8. Bio-Rad Laboratories, Inc.,
9.2.9. Quidel Corporation,
9.2.10. Hologic, Inc.,
9.2.11. Ortho Clinical Diagnostics,
9.2.12. Beckman Coulter, Inc.
9.2.13. BioMérieux SA,
9.2.14. Trinity Biotech plc,
9.2.15. EKF Diagnostics Holdings plc
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們